Evidence map›Paper›PMID 42346009›Full record

ArticleBiotech (Basel (Switzerland))2026

Sustainable Curcumin-Loaded Poly(Glyceryl Adipate) Nanoparticles Attenuate Adjuvant-Induced Arthritis: A Comprehensive Study from Synthesis to Gene Expression Analysis.

Rania H H Ahmed, Mahmoud E Soliman, Sherif F Hammad, Hesham S M Soliman, Ahmed Abdel-Mawgood

Abstract read
In one paragraph

Article in Biotech (Basel (Switzerland)), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rania H H AhmedBiotechnology Program, Faculty of Basic and Applied Science, Egypt-Japan University of Science and Technology, New Borg El-Arab City 21934, Alexandria, Egypt.ORCID 0009-0002-9938-6574
Mahmoud E SolimanDepartment of Pharmaceutics and Industrial Pharmacy, Ain Shams University, Abbassia 11566, Cairo, Egypt.
Sherif F HammadPharmaceutical Chemistry Department, Faculty of Pharmacy, Capital University (Formerly Helwan University), Cairo 11795, Cairo, Egypt.
Hesham S M SolimanPharmacognosy Department, Faculty of Pharmacy, Capital University (Formerly Helwan University), Cairo 11795, Cairo, Egypt.
Ahmed Abdel-MawgoodBiotechnology Program, Faculty of Basic and Applied Science, Egypt-Japan University of Science and Technology, New Borg El-Arab City 21934, Alexandria, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin can behave potently as an anti-inflammatory agent, but unfortunately, it suffers from a detrimental aqueous solubility and a limited bioavailability, which hinders its usage in clinical applications. Formulating a polymeric nanosized biocompatible system can increase the delivered curcumin fraction intra-articularly for inflammatory diseases. Poly(glyceryl adipate) nanoparticles were synthesized using a polycondensation process yielding six different polymers, which was followed by a preparation of different curcumin-loaded formulations using the nanoprecipitation method. The selected formulation exhibited a particle size of 115.8 ± 10.9 nm, a mean PDI of 0.191 ± 0.038, a zeta potential of -22.9 ± 1.5 mV, and an EE of about 95%. This formulation was subjected to physicochemical characterization, including TEM, FTIR, DSC, and an in vitro release study. The stability was assessed in the presence of sodium sulfate at different concentrations, and the long-term stability was assessed through three months of storage. The cytocompatibility was evaluated by an MTT assay on normal and cancerous cell lines, revealing no significant cytotoxicity, and RT-qPCR was done in order to point out the anti-inflammation effect of the produced nanoparticles. Finally, a molecular docking study was held against Bruton's tyrosine kinase. The formulation's findings demonstrate the potential of nanoparticles, providing a basis for further in vivo studies targeting arthritis therapy.

Indexed as

adjuvant-induced arthritis (AIA)biocompatibilitycurcuminin silico molecular dockingintra-articular drug deliverypoly(glyceryl adipate) (PGA)polymeric nanocarrierspro-inflammatory cytokinesrheumatoid arthritissustained drug release

Identifiers

PMID42346009
PMCPMC13297080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.